Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Crohn’s Disease (CD) Treatment Market?

The market size for Crohn’s disease (CD) treatment has exhibited robust growth in the past few years. It is projected to expand from $11.76 billion in 2024 to $12.38 billion in 2025, with a compound annual growth rate (CAGR) of 5.3%. The growth rate attested during the historical period can be traced back to an increase in the incidence of Crohn’s disease, heightened consciousness about the disease, governmental endeavors, and lifestyle changes.

What Growth Rate Is Forecasted for the Crohn’s Disease (CD) Treatment Market by 2029?

The market for Crohn’s disease (CD) treatment is projected to experience considerable expansion over the coming years, expected to reach a value of $15.06 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. The projected growth during this period can be credited to the escalating demand for combined therapies, increased use of biologics, as well as investments being directed towards the research and development of treatments for Crohn’s disease (CD). Forecasts for this period delineate a trend towards the development of biologic drugs, pioneering products, refined diagnostic tools, and the adoption of biosimilars.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12902&type=smp

Which Key Companies Are Shaping the Future of the Crohn’s Disease (CD) Treatment Market?

Major companies operating in the crohn’s disease (cd) treatment market are Pfizer Inc., Johnson and Johnson Ltd., Merck and Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy’s Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC.

Which Factors Are Driving Demand in the Crohn’s Disease (CD) Treatment Industry?

The increasing incidence of inflammatory bowel diseases is anticipated to drive the expansion of the Crohn’s disease (CD) treatment market. A collection of chronic inflammatory diseases mainly impacting the gastrointestinal (GI) tract is known as inflammatory bowel disease (IBD). The benefits of Crohn’s disease (CD) treatment include symptom alleviation, inflammation reduction, remission promotion, and improved quality of life for those afflicted with the chronic condition. For instance, the United States National Library of Medicine, a U.S-based medical resource center, deduced that in Canada, the rate of IBD was calculated at 30 per 100,000 individuals per annum in 2023, speculating a steady increase of about 0.58% annually. By 2023, the prevalence of IBD in Canada was around 825 per 100,000, with predictions hinting this could escalate to 1.1% of the population by 2035. Consequently, this growing prevalence of inflammatory bowel diseases propels the growth of the Crohn’s disease (CD) treatment market.

Market Driver of Crohn’s Disease (CD) Treatment: Boost in Clinical Trials Accelerates Growth in the Market for Crohn’s Disease Treatment

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12902&type=smp

How Is the Crohn’s Disease (CD) Treatment Market Segmented by Several Divisions?

The crohn’s disease (CD) treatment market covered in this report is segmented –

1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types

2) By Route of Administration: Oral, Injectable

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Drug Stores

Subsegments:

1) By Antibiotics: Metronidazole, Ciprofloxacin, Rifaximin

2) By Amino Salicylates: Mesalamine, Sulfasalazine

3) By Corticosteroids: Prednisone, Budesonide, Hydrocortisone

4) By Immunomodulators: Azathioprine, Mercaptopurine, Methotrexate

5) By Other Drug Types: Biologic Therapies, Janus Kinase Inhibitors, Small Molecules

What are the Emerging Market Trends Driving the Growth of the Crohn’s Disease (CD) Treatment Industry?

Leading companies in the Crohn’s disease (CD) treatment sector are adopting novel technologies like IBDSENSE to maintain their market rankings. In March 2023, IBDSENSE was fabricated by The IRR Chemistry Hub, an interdisciplinary hub located in Scotland. The technology is designed to enhance diagnostic and monitoring procedures for inflammatory bowel disease using non-invasive methods, including those for Crohn’s disease. The approach utilizes fluorescence-based technology to evaluate the enzyme activity of Granzyme B (GzmB) in patient bio-samples. This innovation aims to enhance patient experience and provide more treatment options.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/crohns-disease-cd-treatment-global-market-report

Which Regions Are Driving Growth in the Crohn’s Disease (CD) Treatment Market?

North America was the largest region in the Crohn’s disease (CD) treatment market in 2024. The regions covered in Crohn’s disease (CD) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12902

This Report Delivers Insight On:

1. How big is the crohn’s disease (cd) treatment market, and how is it changing globally?

2. Who are the major companies in the crohn’s disease (cd) treatment market, and how are they performing?

3. What are the key opportunities and risks in the crohn’s disease (cd) treatment market right now?

4. Which products or customer segments are growing the most in the crohn’s disease (cd) treatment market?

5. What factors are helping or slowing down the growth of the crohn’s disease (cd) treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model